Equifax (NYSE:EFX) Issues FY 2025 Earnings Guidance

Equifax (NYSE:EFX) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 7.250-7.650 for the period, compared to the consensus EPS estimate of 8.740. The company issued revenue guidance of $5.9 billion-$6.0 billion, compared to the consensus revenue estimate of $6.3 billion. Equifax also updated its Q1 2025 guidance to 1.330-1.430 EPS.

Equifax Price Performance

NYSE:EFX opened at $248.59 on Friday. The company has a quick ratio of 0.88, a current ratio of 0.75 and a debt-to-equity ratio of 0.90. The firm has a market capitalization of $30.81 billion, a price-to-earnings ratio of 51.47, a P/E/G ratio of 3.00 and a beta of 1.58. Equifax has a 12-month low of $213.02 and a 12-month high of $309.63. The stock’s 50 day moving average price is $261.12 and its two-hundred day moving average price is $274.75.

Equifax (NYSE:EFX) last issued its quarterly earnings data on Thursday, February 6th. The credit services provider reported $2.12 EPS for the quarter, meeting analysts’ consensus estimates of $2.12. Equifax had a return on equity of 19.13% and a net margin of 10.63%. On average, analysts anticipate that Equifax will post 7.45 earnings per share for the current year.

Equifax Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, February 21st will be issued a $0.39 dividend. This represents a $1.56 annualized dividend and a yield of 0.63%. The ex-dividend date is Friday, February 21st. Equifax’s dividend payout ratio is currently 32.30%.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on EFX shares. BNP Paribas raised Equifax from a “neutral” rating to an “outperform” rating and set a $305.00 price objective on the stock in a report on Monday, December 16th. JPMorgan Chase & Co. cut their price target on shares of Equifax from $304.00 to $283.00 and set an “overweight” rating on the stock in a report on Tuesday, November 19th. Morgan Stanley lowered their target price on Equifax from $320.00 to $316.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. William Blair reiterated an “outperform” rating on shares of Equifax in a research report on Friday. Finally, Oppenheimer reduced their target price on Equifax from $286.00 to $279.00 and set an “outperform” rating on the stock in a report on Friday. Two investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $300.71.

Insider Buying and Selling

In other news, EVP Lisa M. Nelson sold 551 shares of the company’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $260.39, for a total transaction of $143,474.89. Following the transaction, the executive vice president now directly owns 11,697 shares of the company’s stock, valued at $3,045,781.83. This represents a 4.50 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.57% of the stock is owned by insiders.

Equifax Company Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.